國立高雄大學圖資館 |

登入

回首頁

Drug delivery and targeting

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Drug delivery and targetingedited by Monika Schäfer-Korting, Ulrich S. Schubert.
其他作者:	Schäfer-Korting, Monika.
出版者:	Cham :Springer International Publishing :2024.
面頁冊數:	x, 411 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Drug delivery systems.
電子資源:	https://doi.org/10.1007/978-3-031-52864-4
ISBN:	9783031528644$q(electronic bk.)

Drug delivery and targeting
Drug delivery and targeting[electronic resource] /edited by Monika Schäfer-Korting, Ulrich S. Schubert. - Cham :Springer International Publishing :2024. - x, 411 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v. 2841865-0325 ;. - Handbook of experimental pharmacology ;208..

Part I. Nanoparticles and other Advanced Technologies -- Knowledge-based design of multi-functional polymer-based nanoparticles -- Stimuli-responsive non-viral nanoparticles for gene delivery -- Sustainability in drug and nano-particle processing -- Advanced formulation approaches for proteins -- Microneedles and polymer films - delivery of peptides, proteins and nucleic acids -- Advances in vaccine delivery enhancers - small molecules and nanomaterials -- Biodegradable long acting injectables: Platform technology and industrial challenges -- Part II. Visualization Technologies -- Visualization of Nano-carriers and Drugs in Cells and Tissue -- Characterization of drug delivery systems by transmission electron microscopy -- Part III. Target Specific Delivery -- Blood-brain barrier-crossing strategies for improved treatment of CNS disorders -- Interactions of nano-systems with immune cells and cancer cells - a roadmap to clinical use?- Progress in ocular drug delivery: challenges and constraints -- New therapeutic options in pulmonal diseases - sphingolipids and sphingolipid metabolism -- Molecular therapeutics for pulmonary diseases - the need for drug targeting -- Delivery of mitochondrial RNA -- Part IV. Concerted Actions - Thinking the Drug from the Beginning -- ATMP formulations and delivery -- Preclinical testing and approval of ATMP -- Looking to the future - drug delivery in the prophylaxis and therapy of severe and chronic diseases.

Since the publication of the Handbook of Experimental Pharmacology Vol. 197 in 2010 there have been important advances in drug development, drug delivery and - more recently - drug targeting. This is in particular relevant with the new generation of drugs acting on the immune system and tumors. These are quite often accompanied by major adverse reactions. Safe therapy is, therefore, an important area of research, in particular in chronic diseases and in persons of old age. In addition, the Covid-19 pandemic has brought renewed attention to vaccinations against viral infections, and mRNA vaccines have been tested for vaccination in tumor therapy, too. Vaccine delivery has stimulated important research on carriers which may pave the way for other applications and enhance a path to e.g. CRISPR-cas therapy.

ISBN: 9783031528644$q(electronic bk.)

Standard No.: 10.1007/978-3-031-52864-4doiSubjects--Topical Terms:

196465
Drug delivery systems.

LC Class. No.: RS199.5

Dewey Class. No.: 615.6

Drug delivery and targeting
LDR:03335nmm a2200337 a 4500 001 664212
003 DE-He213
005 20240329105033.0
006 m d
007 cr nn 008maaau
008 241219s2024 sz s 0 eng d
020 $a 9783031528644$q(electronic bk.)
020 $a 9783031528637$q(paper)
024 7 $a 10.1007/978-3-031-52864-4 $2 doi
035 $a 978-3-031-52864-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RS199.5
072 7 $a MQP $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a MQP $2 thema
082 0 4 $a 615.6 $2 23
090 $a RS199.5 $b .D794 2024
245 0 0 $a Drug delivery and targeting $h [electronic resource] / $c edited by Monika Schäfer-Korting, Ulrich S. Schubert.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2024.
300 $a x, 411 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 1865-0325 ; $v v. 284
505 0 $a Part I. Nanoparticles and other Advanced Technologies -- Knowledge-based design of multi-functional polymer-based nanoparticles -- Stimuli-responsive non-viral nanoparticles for gene delivery -- Sustainability in drug and nano-particle processing -- Advanced formulation approaches for proteins -- Microneedles and polymer films - delivery of peptides, proteins and nucleic acids -- Advances in vaccine delivery enhancers - small molecules and nanomaterials -- Biodegradable long acting injectables: Platform technology and industrial challenges -- Part II. Visualization Technologies -- Visualization of Nano-carriers and Drugs in Cells and Tissue -- Characterization of drug delivery systems by transmission electron microscopy -- Part III. Target Specific Delivery -- Blood-brain barrier-crossing strategies for improved treatment of CNS disorders -- Interactions of nano-systems with immune cells and cancer cells - a roadmap to clinical use?- Progress in ocular drug delivery: challenges and constraints -- New therapeutic options in pulmonal diseases - sphingolipids and sphingolipid metabolism -- Molecular therapeutics for pulmonary diseases - the need for drug targeting -- Delivery of mitochondrial RNA -- Part IV. Concerted Actions - Thinking the Drug from the Beginning -- ATMP formulations and delivery -- Preclinical testing and approval of ATMP -- Looking to the future - drug delivery in the prophylaxis and therapy of severe and chronic diseases.
520 $a Since the publication of the Handbook of Experimental Pharmacology Vol. 197 in 2010 there have been important advances in drug development, drug delivery and - more recently - drug targeting. This is in particular relevant with the new generation of drugs acting on the immune system and tumors. These are quite often accompanied by major adverse reactions. Safe therapy is, therefore, an important area of research, in particular in chronic diseases and in persons of old age. In addition, the Covid-19 pandemic has brought renewed attention to vaccinations against viral infections, and mRNA vaccines have been tested for vaccination in tumor therapy, too. Vaccine delivery has stimulated important research on carriers which may pave the way for other applications and enhance a path to e.g. CRISPR-cas therapy.
650 0 $a Drug delivery systems. $3 196465
650 0 $a Drug targeting. $3 194481
650 1 4 $a Pharmacy. $3 218145
650 2 4 $a Pharmacology. $3 218135
650 2 4 $a Translational Research. $3 921022
650 2 4 $a Clinical Research. $3 911843
650 2 4 $a Drug Safety and Pharmacovigilance. $3 701740
700 1 $a Schäfer-Korting, Monika. $3 976893
700 1 $a Schubert, Ulrich S. $3 753161
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 559421
856 4 0 $u https://doi.org/10.1007/978-3-031-52864-4
950 $a Biomedical and Life Sciences (SpringerNature-11642)